Table 2 Baseline and treatment characteristics for patients with LGG (n = 485)
Variable | All patients |
|---|---|
Age, mean (SD) | 46 (14.7) |
Female, n (%) | 215 (44) |
Days from imaging diagnosis to surgery, median (Q1-Q3) | 37 (21–90) |
WHO performance status, n (%) | |
0. Fully active | 263 (55.6) |
1. Light work possible | 124 (26.2) |
2. Cares for self but cannot work | 65 (13.7) |
3. Limited self care | 16 (3.3) |
4. Disabled, confined to bed/chair | 5 (1.1) |
Missing, n | 12 |
Tumour laterality, n (%) | |
Left | 250 (52.2) |
Right | 209 (43.6) |
Bilateral | 20 (4.2) |
Missing, n | 6 |
Tumour size | |
< 4 cm | 177 (40.0) |
4–6 cm | 174 (39.4) |
> 6 cm | 91 (20.6) |
Missing, n | 43 |
History of seizure/epilepsy, n (%) | 351 (72.4) |
Missing, n | 0 |
History of depression, n (%) | 61 (12.6) |
Missing, n | 0 |
History of anxiety and/or sleeping difficulties | 126 (26.0) |
Missing, n | 0 |
Surgical procedure, n (%) | |
Biopsy | 131 (27.3) |
Resection | 349 (72.7) |
Missing, n | 5 |
New deficit after surgery, n (%) | 84 (18.9) |
Missing, n | 40 |
Reoperation due to complication, n (%) | 27 (6.1) |
Missing, n | 41 |